微生物组:对癌症中微生物的新见解
Yingying Ma1, Tao Chen1, Tingting Sun2
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Microbial pathogenesis
|October 31, 2024
概括
瘤内微生物组 (oncomicrobiome) 包括瘤内的微生物,影响癌症的进展和治疗反应. 尽管在瘤学中越来越重要,但研究在方法和建立因果关系方面面临挑战.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 内微生物组,称为内微生物组,由位于瘤细胞,免疫细胞和细胞间基质内的细菌,真菌,病毒和古生物组成.
- 瘤微生物组因其异质性及其与瘤启动,进展,转移和对治疗反应的关联而越来越受认可.
- 肠道微生物组与宿主免疫系统之间的相互作用可以显著调节抗瘤免疫力,影响癌症免疫疗法的有效性.
研究的目的:
- 介绍有关微生物群的基本概念,检测方法,起源和特征.
- 界定瘤微生物组在常见瘤类型中的组成,并阐明其在塑造瘤微环境中的作用.
- 讨论目前阻碍微生物组研究进展的挑战和局限性.
主要方法:
- 审查现有关于oncomicrobiome检测,组成和功能的文献.
- 对研究分析的研究分析了瘤微生物组与瘤发作,进展,转移和治疗反应的关联.
- 讨论方法方面的挑战,包括微生物数量低,污染风险和样本处理偏差.
主要成果:
- 肠道微生物组是癌症生物学中的一个重要因素,影响瘤发育和免疫反应.
- 在各种癌症类型中观察到特定的微生物组和瘤特征之间的关联.
- 显著的方法障碍阻碍了对微生物组研究的全面理解和可重复性.
结论:
- 瘤微生物组是瘤微环境的关键组成部分,对癌症的进展和治疗有深远的影响.
- 需要进一步的研究,以克服现有的方法挑战,并建立确切的机械链接之间的oncomicrobiome和癌症.
- 应对这些挑战对于利用向癌症治疗中的oncomicrobiome治疗潜力至关重要.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
What is Cancer?
10.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


